✦ LIBER ✦

Cysteinyl-leukotriene 1 receptor antagonist attenuates bleomycin-induced pulmonary fibrosis in mice

✍ Scribed by Takehiro Izumo; Mitsuko Kondo; Atsushi Nagai

Book ID: 116719072
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 309 KB
Volume: 80
Category: Article
ISSN: 0024-3205
DOI: 10.1016/j.lfs.2007.02.038

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiflammin-1 attenuates bleomycin-induc

Antiflammin-1 attenuates bleomycin-induced pulmonary fibrosis in mice

✍ Liu, Wei ;Wan, Jing ;Han, Jian-Zhong ;Li, Chen ;Feng, Dan-Dan ;Yue, Shao-Jie ;Hu 📂 Article 📅 2013 🏛 BMJ 🌐 English ⚖ 818 KB

Effects of a leukotriene B4 receptor ant

Effects of a leukotriene B4 receptor antagonist on bleomycin-induced pulmonary fibrosis

✍ Izumo, T.; Kondo, M.; Nagai, A. 📂 Article 📅 2009 🏛 European Respiratory Society 🌐 English ⚖ 490 KB

Mineralocorticoid receptor antagonists a

Mineralocorticoid receptor antagonists attenuate pulmonary inflammation and bleomycin-evoked fibrosis in rodent models

✍ Lieber, Gissela B; Fernandez, Xiomara; Mingo, Garfield G; Jia, Yanlin; Caniga, M 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 702 KB

Montelukast, a cysteinyl leukotriene rec

Montelukast, a cysteinyl leukotriene receptor-1 antagonist, attenuates chronic brain injury after focal cerebral ischaemia in mice and rats

✍ Rui Zhao; Wen-Zhen Shi; Yong-Mei Zhang; San-Hua Fang; Er-Qing Wei 📂 Article 📅 2011 🏛 Pharmaceutical Press 🌐 English ⚖ 579 KB

Montelukast, a cysteinyl leukotriene rec

Montelukast, a cysteinyl leukotriene receptor-1 antagonist, attenuates chronic brain injury after focal cerebral ischaemia in mice and rats

✍ Rui Zhao; Wen-Zhen Shi; Yong-Mei Zhang; San-Hua Fang; Er-Qing Wei 📂 Article 📅 2011 🏛 Pharmaceutical Press 🌐 English ⚖ 579 KB

## Abstract ## Objectives Previously we demonstrated the neuroprotective effect of montelukast, a cysteinyl leukotriene receptor-1 (CysLT1) antagonist, on acute brain injury after focal cerebral ischaemia in mice. In this study, we have determined its effect on chronic brain injury after focal cer

Pranlukast, a cysteinyl leukotriene rece

Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects

✍ Hamilton, Allan; Faiferman, Isidore; Stober, Paul; Watson, Richard M.; O’Byrne, 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 86 KB